The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial of novel agent PBI-05204 in patients with metastatic pancreatic adenocarcinoma (mPDA).
 
Marc Thomas Roth
No Relationships to Disclose
 
Dana Backlund Cardin
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Advaxis (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Synta (Inst); Synta (Inst); Synta (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie
 
Erkut Hasan Borazanci
Consulting or Advisory Role - Biogen (I); Biogen (I); Biogen (I); Biogen (I); Corcep; Corcep; Corcep; Corcep; Fujifilm; Fujifilm; Fujifilm; Fujifilm; Genzyme (I); Genzyme (I); Genzyme (I); Genzyme (I); Ipsen; Ipsen; Ipsen; Ipsen; Novartis (I); Novartis (I); Novartis (I); Novartis (I); Teva (I); Teva (I); Teva (I); Teva (I)
Speakers' Bureau - Biogen (I); Biogen (I); Biogen (I); Biogen (I); Genentech (I); Genentech (I); Genentech (I); Genentech (I); Genzyme (I); Genzyme (I); Genzyme (I); Genzyme (I); Ipsen; Ipsen; Ipsen; Ipsen; Novartis (I); Novartis (I); Novartis (I); Novartis (I); Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Taiho Pharmaceutical; Teva (I); Teva (I); Teva (I); Teva (I)
Research Funding - Ambry Genetics (Inst); Ambry Genetics (Inst); Ambry Genetics (Inst); Ambry Genetics (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Daiichi Sankyo (Inst); Idera (Inst); Idera (Inst); Idera (Inst); Idera (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MabVax (Inst); MabVax (Inst); MabVax (Inst); MabVax (Inst); Minneamrita Therapeutics (Inst); Minneamrita Therapeutics (Inst); Minneamrita Therapeutics (Inst); Minneamrita Therapeutics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Samumed (Inst); Samumed (Inst); Samumed (Inst); Samumed (Inst)
 
Margaux Steinbach
No Relationships to Disclose
 
Vincent J. Picozzi
Stock and Other Ownership Interests - Abbvie; Abbvie; Abbvie; Abbvie; Amgen; Amgen; Amgen; Amgen; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Gilead Sciences; Gilead Sciences; Gilead Sciences; Gilead Sciences; Halozyme; Halozyme; Halozyme; Halozyme
Research Funding - Aduro Biotech; Aduro Biotech; Aduro Biotech; Aduro Biotech; Celgene; Celgene; Celgene; Celgene; FibroGen; FibroGen; FibroGen; FibroGen; Immunomedics; Immunomedics; Immunomedics; Immunomedics; OncoMed; OncoMed; OncoMed; OncoMed
 
Alexander Rosemurgy
Honoraria - Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical
Speakers' Bureau - Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical
Travel, Accommodations, Expenses - Intuitive Surgical; Intuitive Surgical; Intuitive Surgical; Intuitive Surgical
 
Raymond Couric Wadlow
Consulting or Advisory Role - Johnson & Johnson (I); Johnson & Johnson (I); Johnson & Johnson (I); Johnson & Johnson (I)
Research Funding - Abbvie; Abbvie; Abbvie; Abbvie; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; Boston Biomedical; Boston Biomedical; Boston Biomedical; Boston Biomedical; Merck; Merck; Merck; Merck; Peloton Therapeutics; Peloton Therapeutics; Peloton Therapeutics; Peloton Therapeutics; TYME; TYME; TYME; TYME
 
Robert A. Newman
Employment - Phoenix Biotech; Phoenix Biotech; Phoenix Biotech; Phoenix Biotech
Leadership - Phoenix Biotech; Phoenix Biotech; Phoenix Biotech; Phoenix Biotech
Stock and Other Ownership Interests - Phoenix Biotech; Phoenix Biotech; Phoenix Biotech; Phoenix Biotech
Research Funding - Phoenix Biotech; Phoenix Biotech; Phoenix Biotech; Phoenix Biotech
Patents, Royalties, Other Intellectual Property - Phoenix Biotech; Phoenix Biotech; Phoenix Biotech; Phoenix Biotech
Travel, Accommodations, Expenses - Phoenix Biotech; Phoenix Biotech; Phoenix Biotech; Phoenix Biotech
 
Jordan Berlin
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; Arno Therapeutics; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer Health; Bayer Health; Bayer Health; Bayer Health; Celgene; Celgene; Celgene; Celgene; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Cornerstone Pharmaceuticals; Eisai; Eisai; Eisai; Eisai; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Genentech/Roche; Genentech/Roche; Genentech/Roche; Genentech/Roche; ipsen; ipsen; ipsen; ipsen; lsk biopharma; lsk biopharma; lsk biopharma; lsk biopharma; qed therapeutics; qed therapeutics; qed therapeutics; qed therapeutics; Seagen; Seagen; Seagen; Seagen
Research Funding - Bayer (Inst); Bayer (Inst); Bayer (Inst); Bayer (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); BeiGene (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); boston biomedical (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Genentech/Roche (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Loxo (Inst); Loxo (Inst); Loxo (Inst); Loxo (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); Macrogenics (Inst); pfizer (Inst); pfizer (Inst); pfizer (Inst); pfizer (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); Pharmacyclics (Inst); PsiOxus Therapeutics (Inst); PsiOxus Therapeutics (Inst); PsiOxus Therapeutics (Inst); PsiOxus Therapeutics (Inst); Symphogen (Inst); Symphogen (Inst); Symphogen (Inst); Symphogen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; Bayer; Bayer; Bayer; Bayer; boston Biomedical; boston Biomedical; boston Biomedical; boston Biomedical; EMD Serono; EMD Serono; EMD Serono; EMD Serono; Seagen; Seagen; Seagen; Seagen
Other Relationship - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca